Phase II Study of Abraxane in CIMP-high Colorectal Adenocarcinomas and Small Bowel Adenocarcinomas
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Paclitaxel (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 12 Aug 2016 Status changed from active, no longer recruiting to completed.
- 30 Jul 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
- 28 Jul 2015 Planned primary completion date changed from 1 Nov 2016 to 1 Nov 2017 as reported by ClinicalTrials.gov record.